Vir Biotechnology Inc
Change company Symbol lookup
Select an option...
VIR Vir Biotechnology Inc
$NQUSB40401010N Nasdaq US Benchmark Diversified Reta
IVZ Invesco Ltd
SPLK Splunk Inc
TW Tradeweb Markets Inc
CMPGY Compass Group PLC
FCPT Four Corners Property Trust Inc
BMI Badger Meter Inc

Health Care : Biotechnology | Small Cap Growth
Company profile

Vir Biotechnology, Inc. is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. It has assembled four technology platforms focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. The Company's pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus (HBV), influenza A virus, and human immunodeficiency virus (HIV). Its product candidates include Sotrovimab and VIR-7832, VIR-2218, VIR-3434, VIR-2482, VIR-1111. It is engaged in developing differentiated monoclonal antibodies (mAbs) as well as vaccines and small molecules that focuses is on treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). VIR-2218 and VIR-3434, are for the treatment of HBV. VIR-2482 is an investigational IM administered influenza A-neutralizing mAb.


Last Trade
-0.16 (-0.53%)
B/A Size

Market Hours

Closing Price
Day's Change
0.23 (0.77%)
Bid close
Ask close
B/A Size
Day's High
Day's Low

10-day average volume:

Lowe's Companies, Inc. to Host 2022 Analyst and Investor Conference on December 7th

4:30 pm ET November 16, 2022 (PR Newswire) Print

Lowe's Companies, Inc. (NYSE: LOW) announced today that it will hold its 2022 Analyst and Investor Conference at 8 a.m. Eastern time on Wednesday, Dec. 7 in New York City. The company will provide updates on key growth initiatives and long-term financial targets.

A webcast will be available by visiting the Events and Presentations section of the Lowe's Investor Relations website, Supplemental materials will be available at 6 a.m. ET the morning of the event.

What:  2022 Analyst and Investor Conference
When:  8 a.m. Eastern time on Wednesday, Dec. 7
Where: New York, NY or webcast on Events and Presentations section of the Lowe's Investor Relations website
How:   In-person by invitation and live online video webcast

A webcast replay of the call can be accessed from noon EST on Dec. 8, 2022 through Dec. 7, 2023 by visiting Events & Presentations on our Investor Relations website and clicking on 2022 Lowe's Analyst and Investor Conference.

Lowe's Companies, Inc.

Lowe's Companies, Inc. (NYSE: LOW) is a FORTUNE(R) 50 home improvement company serving approximately 19 million customer transactions a week in the United States and Canada. With fiscal year 2021 sales of over $96 billion, Lowe's and its related businesses operate or service nearly 2,200 home improvement and hardware stores and employ over 300,000 associates. Based in Mooresville, N.C., Lowe's supports the communities it serves through programs focused on creating safe, affordable housing and helping to develop the next generation of skilled trade experts. For more information, visit


Contacts: Shareholder / Analyst Inquiries: Media Inquiries:
          Kate Pearlman                    Steve Salazar

View original content to download multimedia:

SOURCE Lowe's Companies, Inc.

comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.